This rapid change can trigger musculoskeletal symptoms even as metabolic health improves
References Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical Programme, 16 September 2025, Novo Nordisk, DAscanio AM, Mullally JA, Frishman WH
A novel PDE4 inhibitor ZX21011 alleviates neuronal apoptosis by decreasing GSK3-mediated Drp1 Ser616 phosphorylation in cerebral ischemia reperfusion
Many people are bothered by hyperpigmentation on their lips
Serious but less common adverse effects include pancreatitis, gallbladder disease, acute kidney injury (particularly in the setting of dehydration from gastrointestinal symptoms), and hypoglycemia when used in combination with insulin or sulfonylureas
When it comes to LCLT, it seems to have its own benefits, a big one being in recovery In a study done on 10 healthy, recreational weight-trained men, ages 18-29, all received 2g of LCLT for a period of 3 weeks, then had a 1 week washout period